Part:BBa_K2114999
pelB_aGFPnano_TEV_10XHis
+++ TEST TEST TEST +++
The discovery of camelid heavy-chain antibodies and their subsequent modification to single-domain antibodies also called nanobodies1,2 provide researchers with a wide range of tools including labeling methods for imaging, receptor modulation or therapeutic agents. They exhibit a small size of only 15 kDa and their easy structure enables a high-efficiency production in bacterial strains such as E. coli. The anti-GFP nanobody represents an established and well characterized variant of those proteins. In order to directly utilize their functionality, the purification of the over-expressed nanobody provides the advantage of acquiring a highly concentrated protein solution. The BioBrick in the iGEM registry BBa_K929104 contains the full sequence of the anti-GFP nanobody. However, the purification of proteins from a bacterial lysate involves a specific affinity tag by which they can be enriched. An anti-GFP nanobody variant containing a 10XHis-Tag and a TEV protease cleavage site was provided to us by our supervisor Dr. Maximilian Ulbrich. The His-Tag enables the purification by standard nickel columns while the TEV cleavage site allows the . To further avoid the formation of inclusion bodies and increase the yield of purified nanobodies an additional pelB leader sequence was included at the N-terminal section of the nanobody resulting in its transport into the periplasmatic space of the expressing E. coli. The pelB leader sequence facilitates the export of the protein into the periplasmatic space and therefore ensures the proper folding of the nanobody by providing an oxidative environment which promotes the formation of the characteristic disulfide bond.
+++ TEST TEST TEST +++
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
| None |